Inventor · disambiguated record
Gordon Moody
Also filed as: MOODY GORDON · MOODY GORDON L
4 granted patents·9 pending applications·12 citations·filing 1985–2024
69Inventor score
Top patents by PatentIndex Score
13 records- 0179US12264190B2Compositions and methods of treating cancer with chimeric antigen receptorsASTRAZENECA AB·Filed 2021·Granted Apr 1, 2025·1 cites·24 claims
- 0270US2024158469A1Compositions and methods of treating cancer with chimeric antigen receptorsASTRAZENECA AB·Filed 2024·Application pending·0 cites
- 0363US6310253B1Preparation of 1,3,5-triamino-2,4,6-trinitrobenzene of submicron particle sizeUS ENERGY·Filed 1985·Granted Oct 30, 2001·7 cites·9 claims
- 0463US2024316106A1Methods for generating primary immune cellsASTRAZENECA AB·Filed 2024·Application pending·0 cites
- 0561US2024350630A1Compositions and methods of treating disease with chimeric antigen receptors to b cell maturation antigen (bcma)ASTRAZENECA AB·Filed 2024·Application pending·0 cites
- 0660US11939382B2Bispecific PD-1 and TIGIT binding proteins and uses thereofMEDIMMUNE LLC·Filed 2022·Granted Mar 26, 2024·0 cites·20 claims
- 0758US2023346941A1Compositions and methods of treating cancer with chimeric antigen receptorsASTRAZENECA AB·Filed 2021·Application pending·0 cites
- 0858US2024117309A1Methods for expanding t cell populationsMEDIMMUNE LLC·Filed 2023·Application pending·0 cites
- 0956US2024228610A9Compositions and methods of treating cancer with chimeric antigen receptors targeting claudin 18.2MEDIMMUNE LLC·Filed 2023·Application pending·0 cites
- 1055US2023192803A1Anti-steap2 chimeric antigen receptors and uses thereofMEDIMMUNE LLC·Filed 2022·Application pending·0 cites
- 1154US2023279352A1Methods for generating primary immune cellsASTRAZENECA AB·Filed 2022·Application pending·0 cites
- 1251US6225503B1Preparation of 1,3,5-triamo-2,4,6-trinitrobenzene of submicron particle sizeUS ENERGY·Filed 1992·Granted May 1, 2001·4 cites·9 claims
- 1347US2023055143A1Compositions and Methods of Treating Cancer with Chimeric Antigen Receptors Targeting Glypican 3MEDIMMUNE LLC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gordon Moody files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →